Overview: Willow vs Noom
Both Willow and Noom provide pathways to GLP-1 medications such as Semaglutide and Tirzepatide. However, their models differ significantly. Willow is a medication-first telehealth provider focused on affordability, speed, and simplicity. Noom is a behavior-change coaching platform that added GLP-1 medications through Noom Med, but at a significantly higher cost due to mandatory coaching and program fees.
Why Willow Wins when comparing Willow vs Noom?
Willow offers the fastest and most affordable pathway to GLP-1 medications without forcing users into expensive add-on programs. The company focuses solely on medical weight management, resulting in a smoother, simpler, and more cost-effective experience.
What Makes Willow Superior
- Lower monthly pricing than Noom
- No mandatory coaching or upsells
- Quick online intake and provider evaluation
- Transparent monthly billing with no hidden fees
- Compounded Semaglutide and Tirzepatide directly shipped to your door
Noom: Coaching Program First, Medication Second
Noom is widely known for its coaching-based model and psychology-driven app. When they added GLP-1 access, they integrated it into their existing habit-based program. This means you cannot access medication through Noom without also paying for coaching, tracking tools, and curriculum-based guidance. While these features may benefit some users, they dramatically increase the monthly cost compared to Willow.
Noom’s Key Limitations
- Higher program cost due to mandatory coaching
- More steps and longer onboarding timeline
- Medication availability varies by region
- Not intended for users who want a medication-focused program
Pricing Comparison
Pricing is one of the most significant differences between Willow vs Noom. Willow’s medication-only structure keeps costs low, while Noom bundles coaching and curriculum into every plan.
| Category | Willow | Noom |
|---|---|---|
| Semaglutide (Compounded) | Lower cost | Higher due to program bundle |
| Tirzepatide (Compounded) | Affordable monthly pricing | More expensive, coaching included |
| Coaching Included | No | Yes, mandatory |
| Labs Required | No | Sometimes required |
Medication Availability
| Medication | Willow | Noom |
|---|---|---|
| Semaglutide (Compounded) (Injectables & Sublingual Tablets) | Yes | Yes |
| Tirzepatide (Compounded) | Yes | Limited |
| Wegovy | No | Yes (availability varies) |
| Zepbound | No | Yes (availability varies) |
Which Platform Is Better for You? (Willow vs Noom)
Choose Willow If You Want:
- Fast approval process
- Affordable GLP-1 treatment without expensive extras
- A simple, medication-first approach
- Predictable monthly costs
Choose Noom If You Want:
- Medication plus habit coaching
- A curriculum-based system for long-term behavior change
- Brand-name GLP-1 options (depending on region)
Final Verdict: Willow Is the Better Choice for GLP-1 Medications
For most people seeking effective and affordable GLP-1 therapy in 2025, Willow is the clear winner. Its lower pricing, simple intake, faster approvals, and medication-focused approach make it more accessible and efficient than Noom’s bundled, coaching-heavy model. While Noom may appeal to those who want intensive behavior coaching, Willow delivers the best overall value for GLP-1 medication access.